1. Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropynmidine dehydrogenase deficiency;Takimoto;Clin Cancer Res,1996
2. Life-threatening toxicity in a dihydropynmidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil;Johnson;Clin Cancer Res,1999
3. Dihydropynmidine dehydrogenase activity Prognostic partner of 5-fluorouracil?;Allegra;Clin Cancer Res,1999
4. Distribution and inhibition of dihydrouracil dehydrogenase activities in human tissues using 5-fluorouracil as a substrate;Ho;Anticancer Res,1986
5. Dihydropynmidine dehydrogenase activity in human peripheral blood mononuclear cells and liver Population characteristics, newly identified deficient patients, and clinical implication in 5-fluorouracil chemotherapy;Lu;Cancer Res,1993